{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "new", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "04", "@timestamp": "2021-06-04T17:36:43.000043-04:00", "@year": "2021", "@month": "06"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "12"}}, "bibrecord": {"head": {"author-group": {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Psychiatry"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113175935"}, "@dptid": "113175935"}, "author": [{"ce:given-name": "Michael", "preferred-name": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:degrees": "Dr.", "ce:surname": "Maes", "@auid": "57218157965", "ce:indexed-name": "Maes M."}]}, "citation-title": "Meet our editorial board member", "abstracts": null, "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Psychiatry"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:degrees": "Dr.", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}}, "citation-info": {"citation-type": {"@code": "ed"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "CNS Neurol. Disord. Drug Targets", "website": {"ce:e-address": {"$": "www.eurekaselect.com/646/journal/cns-amp-neurological-disorders-drug-targets", "@type": "email"}}, "@country": "are", "translated-sourcetitle": {"$": "CNS and Neurological Disorders - Drug Targets", "@xml:lang": "eng"}, "issn": [{"$": "19963181", "@type": "electronic"}, {"$": "18715273", "@type": "print"}], "volisspag": {"voliss": {"@volume": "15", "@issue": "10"}, "pagerange": {"@first": "1199", "@last": "1200"}}, "@type": "j", "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Bentham Science Publishers"}, "sourcetitle": "CNS and Neurological Disorders - Drug Targets", "@srcid": "4500151409", "publicationdate": {"month": "12", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 December 2016"}, "day": "01"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": {"classification-code": "8", "classification-description": "Neurology and Neurosurgery"}}, {"@type": "ASJC", "classification": [{"$": "2800"}, {"$": "3004"}]}, {"@type": "SUBJABBR", "classification": [{"$": "NEUR"}, {"$": "PHAR"}]}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": {"cas-registry-number": "303-98-0", "chemical-name": "ubidecarenone"}}}}}, "item-info": {"copyright": {"$": "Copyright 2021 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "02", "@timestamp": "BST 14:55:41", "@year": "2021", "@month": "06"}}, "itemidlist": {"itemid": [{"$": "613283004", "@idtype": "PUI"}, {"$": "658235934", "@idtype": "CAR-ID"}, {"$": "20160842878", "@idtype": "EMBASE"}, {"$": "20162350901", "@idtype": "REAXYSCAR"}, {"$": "20167275090", "@idtype": "SCOPUS"}, {"$": "85106843244", "@idtype": "SCP"}, {"$": "85106843244", "@idtype": "SGR"}], "ce:doi": "10.2174/187152731510161018153546"}}, "tail": {"bibliography": {"@refcount": "5", "reference": [{"ref-fulltext": "Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012; 36(2): 764-85.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression"}, "refd-itemidlist": {"itemid": {"$": "84855801183", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "36", "@issue": "2"}, "pagerange": {"@first": "764", "@last": "785"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Leonard", "ce:indexed-name": "Leonard B."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}]}, "ref-sourcetitle": "Neurosci Biobehav Rev"}}, {"ref-fulltext": "Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of Major Depressive Disorder: Pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013; 18(5): 595-606.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "The neuroprogressive nature of Major Depressive Disorder: Pathways to disease evolution and resistance, and therapeutic implications"}, "refd-itemidlist": {"itemid": {"$": "84876670027", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18", "@issue": "5"}, "pagerange": {"@first": "595", "@last": "606"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Moylan", "ce:indexed-name": "Moylan S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, {"@seq": "3", "ce:initials": "N.R.", "@_fa": "true", "ce:surname": "Wray", "ce:indexed-name": "Wray N.R."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Berk", "ce:indexed-name": "Berk M."}]}, "ref-sourcetitle": "Mol Psychiatry"}}, {"ref-fulltext": "Maes M, Twisk FNM, Ringel K. Inflammatory and cell-mediated immune biomarkers in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and depression: inflammatory markers higher in ME/CFS than in depression. Psychother Psychosom 2012; 81(5): 286-95.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Inflammatory and cell-mediated immune biomarkers in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and depression: Inflammatory markers higher in ME/CFS than in depression"}, "refd-itemidlist": {"itemid": {"$": "84864103871", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "81", "@issue": "5"}, "pagerange": {"@first": "286", "@last": "295"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Twisk", "ce:indexed-name": "Twisk F."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ringel", "ce:indexed-name": "Ringel K."}]}, "ref-sourcetitle": "Psychother Psychosom"}}, {"ref-fulltext": "Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand 2013; 127(5): 344-54.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes"}, "refd-itemidlist": {"itemid": {"$": "84875300745", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "127", "@issue": "5"}, "pagerange": {"@first": "344", "@last": "354"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kubera", "ce:indexed-name": "Kubera M."}, {"@seq": "3", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Leunis", "ce:indexed-name": "Leunis J.C."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Berk", "ce:indexed-name": "Berk M."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Geffard", "ce:indexed-name": "Geffard M."}, {"@seq": "6", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Bosmans", "ce:indexed-name": "Bosmans E."}]}, "ref-sourcetitle": "Acta Psychiatr Scand"}}, {"ref-fulltext": "Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013; 11: 200.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "So depression is an inflammatory disease, but where does the inflammation come from?"}, "refd-itemidlist": {"itemid": {"$": "84884354746", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "200"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Berk", "ce:indexed-name": "Berk M."}, {"@seq": "2", "ce:initials": "L.J.", "@_fa": "true", "ce:surname": "Williams", "ce:indexed-name": "Williams L.J."}, {"@seq": "3", "ce:initials": "F.N.", "@_fa": "true", "ce:surname": "Jacka", "ce:indexed-name": "Jacka F.N."}], "et-al": null}, "ref-sourcetitle": "BMC Med"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "prism:issueIdentifier": "10", "eid": "2-s2.0-85106843244", "prism:coverDate": "2016-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85106843244", "subtypeDescription": "Editorial", "dc:creator": {"author": [{"ce:given-name": "Michael", "preferred-name": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "Dr.", "ce:surname": "Maes", "@auid": "57218157965", "author-url": "https://api.elsevier.com/content/author/author_id/57218157965", "ce:indexed-name": "Maes M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85106843244"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106843244&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85106843244&origin=inward"}], "prism:publicationName": "CNS and Neurological Disorders - Drug Targets", "source-id": "4500151409", "citedby-count": "0", "prism:volume": "15", "subtype": "ed", "prism:pageRange": "1199-1200", "dc:title": "Meet our editorial board member", "prism:endingPage": "1200", "openaccess": "0", "openaccessFlag": "false", "prism:doi": "10.2174/187152731510161018153546", "prism:issn": "19963181 18715273", "prism:startingPage": "1199", "dc:identifier": "SCOPUS_ID:85106843244", "dc:publisher": "Bentham Science Publishers"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Neuroscience (all)", "@code": "2800", "@abbrev": "NEUR"}, {"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}]}, "authors": {"author": [{"ce:given-name": "Michael", "preferred-name": {"ce:given-name": "Michael", "ce:initials": "M.", "ce:surname": "Maes", "ce:indexed-name": "Maes M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "Dr.", "ce:surname": "Maes", "@auid": "57218157965", "author-url": "https://api.elsevier.com/content/author/author_id/57218157965", "ce:indexed-name": "Maes M."}]}}}